Patents by Inventor Edward Parsonage

Edward Parsonage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170027117
    Abstract: The present disclosure is directed to a method for providing a flow-able hydrogel for germinating, cultivating, transporting or displaying plants. The method generally includes at least three distinct steps: 1) dissolving a polyethylene glycol having functionalized end-groups in water to form a flow-able solution, 2) dissolving one or more activating agents within the flow-able solution such that the activating agents react with the functionalized end-groups of the polyethylene glycol to form a non-flow-able hydrogel after a set-time, 3) pouring the flow-able solution into a container prior to the set time such that the flow-able solution assumes the shape of the container and forms a non-flow-able hydrogel.
    Type: Application
    Filed: July 18, 2016
    Publication date: February 2, 2017
    Inventors: Edward Parsonage, Benjamin Parsonage
  • Patent number: 9463103
    Abstract: The present invention provides medical devices comprising nanocomposite materials. By utilizing nanocomposites in the production thereof, the inventive medical devices can be produced with various advantageous properties. Methods of producing the inventive medical devices are also provided. Inasmuch as the inventive devices are expected to provide certain advantages in their use, there is also provided a method of medical care including methods of treatment or diagnosis, wherein the inventive devices are brought into therapeutic contact with a body to be treated or diagnosed thereby.
    Type: Grant
    Filed: February 22, 2012
    Date of Patent: October 11, 2016
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Edward Parsonage, Daniel J. Horn, John J. Chen, Paul J. Miller, Douglas A. Devens, Jr., Jan Weber
  • Patent number: 8449903
    Abstract: The present invention is directed to bioabsorbable medical devices which are introduced into the body of a subject in a first configuration and deformed in the subject's body to a second configuration. The devices generally include at least one bioabsorbable expandable device component that comprises at least one type of biodegradable polymer. In accordance with an aspect of the invention, the expandable device component is crosslinked while in an expanded configuration. The crosslinked device component is then heated to a temperature above the glass transition temperature (Tg) of the material forming the device component. Upon heating to this temperature, the device component is compressed into a contracted configuration and cooled to below the Tg of the material to maintain the contracted configuration.
    Type: Grant
    Filed: June 4, 2010
    Date of Patent: May 28, 2013
    Assignee: Boston Scientific Scimed, Inc.
    Inventor: Edward Parsonage
  • Publication number: 20120150109
    Abstract: The present invention provides medical devices comprising nanocomposite materials. By utilizing nanocomposites in the production thereof, the inventive medical devices can be produced with various advantageous properties. Methods of producing the inventive medical devices are also provided. Inasmuch as the inventive devices are expected to provide certain advantages in their use, there is also provided a method of medical care including methods of treatment or diagnosis, wherein the inventive devices are brought into therapeutic contact with a body to be treated or diagnosed thereby.
    Type: Application
    Filed: February 22, 2012
    Publication date: June 14, 2012
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Edward Parsonage, Daniel J. Horn, John J. Chen, Paul J. Miller, Douglas A. Devens, JR., Jan Weber
  • Patent number: 8133250
    Abstract: The present invention provides medical devices comprising nanocomposite materials. By utilizing nanocomposites in the production thereof, the inventive medical devices can be produced with various advantageous properties. Methods of producing the inventive medical devices are also provided. Inasmuch as the inventive devices are expected to provide certain advantages in their use, there is also provided a method of medical care including methods of treatment or diagnosis, wherein the inventive devices are brought into therapeutic contact with a body to be treated or diagnosed thereby.
    Type: Grant
    Filed: September 21, 2009
    Date of Patent: March 13, 2012
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Edward Parsonage, Daniel J. Horn, John J. Chen, Paul J. Miller, Douglas A. Devens, Jr., Jan Weber
  • Publication number: 20110318421
    Abstract: The present disclosure is directed to surface functionalized ceramic nanoparticles. The method for producing the surface functionalized ceramic nanoparticles generally includes at least four distinct steps: 1) synthesis of an amphiphilic surfactant having the desired surface functionality, 2) formation of mixed solvent microstructured solution with the surfactant, 3) synthesis of the desired ceramic within the microstructured solution, and 4) chemical attachment of the surfactant to the ceramic nanoparticle. The composition of the surface functionalized nanoparticle comprises a lipophilic component, a hydrophilic component, a chelating agent and a ceramic forming component.
    Type: Application
    Filed: August 8, 2011
    Publication date: December 29, 2011
    Inventor: Edward Parsonage
  • Patent number: 7863387
    Abstract: Fluoropolymers having a —CF adjacent to a —CH which are subsequently dehydrofluorinated to create a —C?C— can be used as controlled release carriers for therapeutic agent(s) by covalently conjugating the therapeutic agent(s) to the fluoropolymer at the —C?C—.
    Type: Grant
    Filed: October 25, 2007
    Date of Patent: January 4, 2011
    Assignee: Boston Scientific Scimed, Inc.
    Inventor: Edward Parsonage
  • Publication number: 20100310624
    Abstract: The present invention is directed to bioabsorbable medical devices which are introduced into the body of a subject in a first configuration and deformed in the subject's body to a second configuration. The devices generally include at least one bioabsorbable expandable device component that comprises at least one type of biodegradable polymer. In accordance with an aspect of the invention, the expandable device component is crosslinked while in an expanded configuration. The crosslinked device component is then heated to a temperature above the glass transition temperature (Tg) of the material forming the device component. Upon heating to this temperature, the device component is compressed into a contracted configuration and cooled to below the Tg of the material to maintain the contracted configuration.
    Type: Application
    Filed: June 4, 2010
    Publication date: December 9, 2010
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventor: Edward Parsonage
  • Patent number: 7758635
    Abstract: An endovascular stent comprising an expandable framework including a plurality of interconnected segments, and a plurality of entangled cylindrical micelles disposed on the expandable framework. Each of the plurality of cylindrical micelles may be loaded with a therapeutic agent.
    Type: Grant
    Filed: February 13, 2007
    Date of Patent: July 20, 2010
    Assignee: Boston Scientific Scimed, Inc.
    Inventor: Edward Parsonage
  • Publication number: 20100010440
    Abstract: The present invention provides medical devices comprising nanocomposite materials. By utilizing nanocomposites in the production thereof, the inventive medical devices can be produced with various advantageous properties. Methods of producing the inventive medical devices are also provided. Inasmuch as the inventive devices are expected to provide certain advantages in their use, there is also provided a method of medical care including methods of treatment or diagnosis, wherein the inventive devices are brought into therapeutic contact with a body to be treated or diagnosed thereby.
    Type: Application
    Filed: September 21, 2009
    Publication date: January 14, 2010
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Edward Parsonage, Daniel J. Horn, John J. Chen, Paul J. Miller, Douglas A. Devens, JR., Jan Weber
  • Patent number: 7591831
    Abstract: The present invention provides medical devices comprising nanocomposite materials. By utilizing nanocomposites in the production thereof, the inventive medical devices can be produced with various advantageous properties. Methods of producing the inventive medical devices are also provided. Inasmuch as the inventive devices are expected to provide certain advantages in their use, there is also provide a method of medical care including methods of treatment or diagnosis, wherein the inventive devices are brought into therapeutic contact with a body to be treated or diagnosed thereby.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: September 22, 2009
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Edward Parsonage, Daniel J. Horn, John J. Chen, Paul J. Miller, Douglas A. Devens, Jr., Jan Weber
  • Publication number: 20090111960
    Abstract: Fluoropolymers having a —CF adjacent to a —CH which are subsequently dehydrofluorinated to create a —C?C— can be used as controlled release carriers for therapeutic agent(s) by covalently conjugating the therapeutic agent(s) to the fluoropolymer at the —C?C—.
    Type: Application
    Filed: October 25, 2007
    Publication date: April 30, 2009
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventor: Edward Parsonage
  • Patent number: 7459192
    Abstract: A substantially tubular member comprises a body. The body is constructed from a first material and has an external surface. At least a portion of the external surface has a predetermined pattern of a second material deposited thereon. The predetermined pattern of the second material is deposited on the at least a portion of the external surface by one or more printing processes such as solution coating, spray coating, thermal printing, piezo jet printing, contact printing and any combination thereof.
    Type: Grant
    Filed: December 28, 2004
    Date of Patent: December 2, 2008
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Edward Parsonage, Paul J. Miller
  • Publication number: 20080195192
    Abstract: An endovascular stent comprising an expandable framework including a plurality of interconnected segments, and a plurality of entangled cylindrical micelles disposed on the expandable framework. Each of the plurality of cylindrical micelles may be loaded with a therapeutic agent.
    Type: Application
    Filed: February 13, 2007
    Publication date: August 14, 2008
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventor: Edward Parsonage
  • Publication number: 20070219528
    Abstract: A medical tubing is disclosed which includes a first material extending between proximal and distal ends of the tubing and which defines a lumen of the tubing. The tubing also includes a second material extending between at least portion of the distance between the proximal and distal ends of the tubing and that is embedded in the first material. The second material is fractured. The first material is flexible and the second material is relatively rigid and brittle and the two materials combined to provide a medical tubing that exhibits strain softening behavior.
    Type: Application
    Filed: May 2, 2007
    Publication date: September 20, 2007
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: John Chen, Douglas Devens, Paul Miller, Edward Parsonage
  • Publication number: 20070134288
    Abstract: Coated medical devices and methods for coating such devices are disclosed. The invention is directed to the use of an anti-adhesion agent in a coating for a medical device. More particularly, the invention is directed to a medical device comprising an anti-adhesion agent that prevents the self-adhesion of different portions of a coating disposed on the surface of the medical device. Additionally, this invention is directed to methods for coating such a medical device.
    Type: Application
    Filed: December 13, 2005
    Publication date: June 14, 2007
    Inventors: Edward Parsonage, James Lasch, Steve Kangas, Jan Seppala
  • Patent number: 7228878
    Abstract: A medical tubing is disclosed which includes a first material extending between proximal and distal ends of the tubing and which defines a lumen of the tubing. The tubing also includes a second material extending between at least portion of the distance between the proximal and distal ends of the tubing and that is embedded in the first material. The second material is fractured. The first material is flexible and the second material is relatively rigid and brittle and the two materials combined to provide a medical tubing that exhibits strain softening behavior.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: June 12, 2007
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: John Jianhua Chen, Douglas A. Devens, Jr., Paul James Miller, Edward Parsonage
  • Patent number: 7112357
    Abstract: A medical device comprising a first substrate, a second substrate and a powder coated tie layer between the first and second substrates resulting in a multilayer construction.
    Type: Grant
    Filed: January 23, 2002
    Date of Patent: September 26, 2006
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Paul Miller, Yigun (Bruce) Wang, Chaunting You, Edward Parsonage
  • Publication number: 20060204698
    Abstract: A medical device comprising a first substrate, a second substrate and a powder coated tie layer between the first and second substrates resulting in a multilayer construction.
    Type: Application
    Filed: May 10, 2006
    Publication date: September 14, 2006
    Inventors: Paul Miller, Yigun (Bruce) Wang, Chaunting You, Edward Parsonage
  • Publication number: 20060088566
    Abstract: A coated medical device have a drug and a nucleating agent thereon. Also provided are methods of increasing or decreasing the size of drug particles on a coated substrate through the use of nucleating agents to thereby increase or decrease the release rate of the drug from the coated substrate.
    Type: Application
    Filed: October 27, 2004
    Publication date: April 27, 2006
    Inventors: Edward Parsonage, Steve Kangas, Timothy Girton